RocketTickers

Krystal Biotech Announces Positive Interim Results from Phase 1/

Long
NASDAQ:KRYS   Krystal Biotech, Inc
KRYS: Krystal Biotech , Inc.
2020-05-14 08:00:10
Krystal Biotech Announces Positive Interim Results from Phase 1/2 Clinical Trial of KB105 in Patients with TGM1-related Autosomal Recessive Congenital Ichthyosis ( ARCI )
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.